Loading...
The way Conson & Colson was going to secure stakes in the A-Bio Cancer Laboratory… David didn’t think Young-Joon would give it to him that easily, but it really wasn’t simple.
“Conson & Colson have a patent for the Chimeric Antigen Receptor T-cell Therapy, one of the third-generation cancer immunotherapies. Schumatix originally had it, but it was transferred to Conson & Colson.”
‘No…’
David felt dizzy.
‘Please not that technology.’
This technology was basically the future of Conson & Colson.
David’s heart began beating wildly. He tried to keep a calm face.
Young-Joon said, “Please transfer that international patent to the A-Bio Cancer Laboratory. Then, I will give you shares.”
Chimeric antigen receptor T-cell therapy, or CAR-T therapy, was a technology where one used immune cells to eliminate cancer. There was a mechanism in the body where immune cells tracked down cancer cells and destroyed them. It was a natural defense that the human body used to remove cancer on its own, and the chimeric immunotherapy helped that work better.
The process was extremely complicated. They would have to harvest T-cells, a type of immune cells, from the body and then manipulate their DNA. Then, they would attach a material that would allow the T-cell to recognize cancer cells better. And after the T-cells were injected into the body, they would find the cancer cells and destroy them. It was a treatment method...
Unlock free chapters every day
Bookmark your novel and never lose track of your progress
Share your thoughts with your favorite translator in the comments.
